ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 997,21
0,50%
Dow Jones
38 815,83
0,36%
DAX
18 158,04
0,91%
Brent Oil
83,31
0,22%
Bitcoin
64 159,04
0,25%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) Actualités

SPRC SciSparc Ltd

1,25
-0,01 (-0,79%)
Dernière mise à jour : 16:07:58
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
SciSparc Ltd SPRC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,01 -0,79% 1,25 16:07:58
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,25 1,25 1,29 1,26
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/4/202414:15GLOBESciSparc to Acquire AutoMax
21/3/202413:58GLOBESciSparc: MitoCareX Unveils Groundbreaking Discovery of..
18/3/202412:29GLOBESciSparc Granted Another Patent, Strengthening its Core..
14/3/202413:49GLOBESciSparc Achieves Major Milestone with First Patient Dosed..
12/3/202413:14GLOBESciSparc: MitoCareX Reveals Promising Results with Discovery..
08/3/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/3/202413:11GLOBESciSparc Announces Enrollment of First Patient for its..
07/3/202413:49GLOBESciSparc Granted Patent for Core Technology in Multiple..
07/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/3/202422:41GLOBESciSparc Issued Canadian Patent for Opioids Reduction Use in..
29/2/202415:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202414:35GLOBESciSparc Delivers Treatment for Autism Spectrum Disorder..
27/2/202422:15EDGAR2Form F-1 - Registration statement for certain foreign..
27/2/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202413:58GLOBEClearmind Medicine Submits Three Additional International..
20/2/202422:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202413:14GLOBEClearmind Medicine Submits Three International Patent..
12/2/202422:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202413:18GLOBESciSparc Announces Initiation of Patient Recruitment for its..
25/1/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202413:42GLOBESciSparc Ltd. Announces $20 Million Standby Equity Purchase..
22/1/202412:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202415:28GLOBESciSparc Advances the Acquisition Process of a Leading..
04/1/202413:18GLOBESciSparc and Clearmind Medicine Reflect on Successful..
13/12/202314:18GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
08/12/202314:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/12/202315:05GLOBESciSparc Provides Updates Regarding the Non-Binding Letter..
01/12/202314:14GLOBEWeight Loss Treatment: SciSparc’s Obesity Drug Showed..
28/11/202322:55EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
28/11/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202314:55GLOBESciSparc Adopts Limited Duration Shareholder Rights Plan
28/11/202314:25GLOBESciSparc Announces Positive Results from its Weight Loss and..
27/11/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202314:41GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
24/11/202314:55GLOBENew Hope for Children: SciSparc's patented CBD- Enhanced..
22/11/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202313:42GLOBESciSparc Signs Non-Binding Letter of Intent to Merge with..
20/11/202322:22EDGAR2Form F-3/A - Registration statement by foreign private..
15/11/202314:01GLOBESciSparc Celebrates Major Breakthrough: Positive Results..
10/11/202315:10GLOBESciSparc Aims to Change Tourette Syndrome Treatments; Will..
03/11/202321:06EDGAR2Form F-3 - Registration statement by foreign private issuers
31/10/202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202312:38GLOBESciSparc Granted Patent from the Australian Patent Office..
24/10/202313:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202313:20GLOBESciSparc Granted Patent for its Core Technology From the..
18/10/202312:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NASDAQ
SPRC
SciSparc
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés